CALIFORNIA CAPITAL EQUITY LLC has a total of 35 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Canada, Brazil and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CARRUTHERS NICHOLAS I, TECHFIELDS INC and BELL IAN M.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 9 | |
#2 | Brazil | 8 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | Republic of Korea | 6 | |
#5 | China | 4 | |
#6 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Tao Chunlin | 32 |
#2 | Desai Neil | 27 |
#3 | Wang Qinwei | 26 |
#4 | Nallan Laxman | 22 |
#5 | Polat Tulay | 22 |
#6 | Ho David | 12 |
#7 | Sun Xiaowen | 11 |
#8 | Koroniak Lukasz | 10 |
#9 | Han Hongna | 6 |
#10 | Desai Neil P | 4 |
Publication | Filing date | Title |
---|---|---|
EP2440057A1 | Triazine derivatives and their therapeutical applications | |
CA2764980A1 | Styryl-triazine derivatives and their therapeutical applications | |
CA2765047A1 | Pyridyl-triazine inhibitors of hedgehog signaling | |
KR20120026612A | Benzyl substituted triazine derivatives and their therapeutical applications |